Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Ixabepilone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,494,337Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Data from Allarity's PII Trial of IXEMPRA Indicate Potential for Benefit in DRP
    Data from Allarity's PII Trial of IXEMPRA Indicate Potential for Benefit in DRP

    05 Jul 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/07/05/2699631/0/en/Initial-Data-from-Allarity-s-Phase-2-Trial-of-IXEMPRA-Indicate-Potential-for-Improved-Clinical-Benefit-in-DRP-Selected-Metastatic-Breast-Cancer-Patients.html

    GLOBENEWSWIRE
    05 Jul 2023
    Share Share
    Oncology Venture advancing towards next milestone clinical Dev of IXEMPRA®.
    Oncology Venture advancing towards next milestone clinical Dev of IXEMPRA®.

    13 Nov 2019

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2019/11/13/1946075/0/en/Oncology-Venture-advancing-towards-next-milestone-in-its-clinical-development-of-IXEMPRA.html

    GLOBENEWSWIRE
    13 Nov 2019
    Share Share
    Copycats wanted: Pfizer, AZ and more under threat as China solicits generics
    Copycats wanted: Pfizer, AZ and more under threat as China solicits generics

    21 Jun 2019

    // Angus Liu FIERCE PHARMA

    https://www.fiercepharma.com/pharma-asia/foreign-drugmakers-under-threat-as-china-rolls-out-drug-list-to-boost-generic

    Angus Liu FIERCE PHARMA
    21 Jun 2019
    Share Share